IRL-1117

N/A

Report date: 2024/02/29 15:22:41

Base Information

Drug NameIRL-1117
Drug Alias NameIRL1117IRL-1117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonistsDopamine D2 receptor agonists
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIrlab Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesIrlab Therapeutics AB
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A